Cargando…
Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study
The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear impla...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909702/ https://www.ncbi.nlm.nih.gov/pubmed/35270201 http://dx.doi.org/10.3390/ijerph19052503 |
_version_ | 1784666247236943872 |
---|---|
author | Lassaletta, Luis Calvino, Miryam Sanchez-Cuadrado, Isabel Skarzynski, Piotr Henryk Cywka, Katarzyna B. Czajka, Natalia Kutyba, Justyna Tavora-Vieira, Dayse van de Heyning, Paul Mertens, Griet Staecker, Hinrich Humphrey, Bryan Zernotti, Mario Zernotti, Maximo Magele, Astrid Ploder, Marlene Zabeu, Julia Speranza |
author_facet | Lassaletta, Luis Calvino, Miryam Sanchez-Cuadrado, Isabel Skarzynski, Piotr Henryk Cywka, Katarzyna B. Czajka, Natalia Kutyba, Justyna Tavora-Vieira, Dayse van de Heyning, Paul Mertens, Griet Staecker, Hinrich Humphrey, Bryan Zernotti, Mario Zernotti, Maximo Magele, Astrid Ploder, Marlene Zabeu, Julia Speranza |
author_sort | Lassaletta, Luis |
collection | PubMed |
description | The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear implant (VIBRANT SOUNDBRIDGE (VSB)), or active transcutaneous bone conduction implant (the BONEBRIDGE (BB)) recipients. Generic QoL and disease-specific QoL were assessed at three intervals: pre-activation, 6 months of device use, and 12 months of device use. 169 participants completed the study (110 CI, 18VSB, and 41BB). CI users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. On some device-specific measures, their QoL also significantly increased between 6 and 12 m device use. VSB users’ QoL significantly increased between all tested intervals with the disease-specific measure but not the generic measure. BB users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. In sum, HI users experienced significant postoperative increases in QoL within their first 12 m of device use, especially when disease-specific measures were used. Disease-specific QoL measures appeared to be more sensitive than their generic counterparts. |
format | Online Article Text |
id | pubmed-8909702 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89097022022-03-11 Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study Lassaletta, Luis Calvino, Miryam Sanchez-Cuadrado, Isabel Skarzynski, Piotr Henryk Cywka, Katarzyna B. Czajka, Natalia Kutyba, Justyna Tavora-Vieira, Dayse van de Heyning, Paul Mertens, Griet Staecker, Hinrich Humphrey, Bryan Zernotti, Mario Zernotti, Maximo Magele, Astrid Ploder, Marlene Zabeu, Julia Speranza Int J Environ Res Public Health Article The primary objectives of this study were to evaluate the effect of hearing implant (HI) use on quality of life (QoL) and to determine which QoL measure(s) quantify QoL with greater sensitivity in users of different types of HIs. Participants were adult cochlear implant (CI), active middle ear implant (VIBRANT SOUNDBRIDGE (VSB)), or active transcutaneous bone conduction implant (the BONEBRIDGE (BB)) recipients. Generic QoL and disease-specific QoL were assessed at three intervals: pre-activation, 6 months of device use, and 12 months of device use. 169 participants completed the study (110 CI, 18VSB, and 41BB). CI users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. On some device-specific measures, their QoL also significantly increased between 6 and 12 m device use. VSB users’ QoL significantly increased between all tested intervals with the disease-specific measure but not the generic measure. BB users’ QoL significantly increased from 0–6 m device use on both the generic- and the disease-specific measures. In sum, HI users experienced significant postoperative increases in QoL within their first 12 m of device use, especially when disease-specific measures were used. Disease-specific QoL measures appeared to be more sensitive than their generic counterparts. MDPI 2022-02-22 /pmc/articles/PMC8909702/ /pubmed/35270201 http://dx.doi.org/10.3390/ijerph19052503 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lassaletta, Luis Calvino, Miryam Sanchez-Cuadrado, Isabel Skarzynski, Piotr Henryk Cywka, Katarzyna B. Czajka, Natalia Kutyba, Justyna Tavora-Vieira, Dayse van de Heyning, Paul Mertens, Griet Staecker, Hinrich Humphrey, Bryan Zernotti, Mario Zernotti, Maximo Magele, Astrid Ploder, Marlene Zabeu, Julia Speranza Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title | Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title_full | Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title_fullStr | Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title_full_unstemmed | Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title_short | Using Generic and Disease-Specific Measures to Assess Quality of Life before and after 12 Months of Hearing Implant Use: A Prospective, Longitudinal, Multicenter, Observational Clinical Study |
title_sort | using generic and disease-specific measures to assess quality of life before and after 12 months of hearing implant use: a prospective, longitudinal, multicenter, observational clinical study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909702/ https://www.ncbi.nlm.nih.gov/pubmed/35270201 http://dx.doi.org/10.3390/ijerph19052503 |
work_keys_str_mv | AT lassalettaluis usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT calvinomiryam usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT sanchezcuadradoisabel usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT skarzynskipiotrhenryk usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT cywkakatarzynab usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT czajkanatalia usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT kutybajustyna usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT tavoravieiradayse usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT vandeheyningpaul usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT mertensgriet usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT staeckerhinrich usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT humphreybryan usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT zernottimario usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT zernottimaximo usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT mageleastrid usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT plodermarlene usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy AT zabeujuliasperanza usinggenericanddiseasespecificmeasurestoassessqualityoflifebeforeandafter12monthsofhearingimplantuseaprospectivelongitudinalmulticenterobservationalclinicalstudy |